Patents by Inventor Kenneth L. Brigham

Kenneth L. Brigham has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20150039332
    Abstract: The present invention includes techniques for providing multilevel simulations for healthcare delivery systems. Computational methods may be used to transform the healthcare delivery market to a more efficient model. Multilevel simulations may provide the means to explore a wide range of possibilities, enabling the early identification of good ideas and the discarding of bad ones. This enables simulating the behavior of, among other things, health care policies, strategies, plans, and management practices prior to roll out to avoid, for example, higher-order and unintended consequences.
    Type: Application
    Filed: July 31, 2014
    Publication date: February 5, 2015
    Inventors: HYUNWOO PARK, TRUSTIN CLEAR, WILLIAM B. ROUSE, RAHUL C. BASOLE, MARK L. BRAUNSTEIN, KENNETH L. BRIGHAM, LYNN CUNNINGHAM
  • Patent number: 7074399
    Abstract: The present invention provides compositions, methods, and kits for treating inflammation and regulating inflammatory responses including cytokine, prostanoid, prostaglandin, and growth factor expression.
    Type: Grant
    Filed: February 20, 2001
    Date of Patent: July 11, 2006
    Assignee: Vanderbilt University
    Inventors: Kenneth L. Brigham, Arlene A. Stecenko, Linda Sealy
  • Publication number: 20020082204
    Abstract: The present invention provides compositions, methods, and kits for treating inflammation and regulating inflammatory responses including cytokine, prostanoid, prostaglandin, and growth factor expression.
    Type: Application
    Filed: February 20, 2001
    Publication date: June 27, 2002
    Inventors: Kenneth L. Brigham, Arlene A. Stecenko, Linda Sealy
  • Patent number: 5676954
    Abstract: A method of expressing a foreign gene in cells of a mammalian organ in vivo includes the step of injecting genetic material capable of inducing desired gene products into a mammal. The genetic material is complexed to cationic liposome carriers. The genetic material is lipofected into cells of the mammalian organ. Gene expression and cellular function of the genetic material are activated to produce the desired foreign products in the cells of the organ.
    Type: Grant
    Filed: May 8, 1995
    Date of Patent: October 14, 1997
    Assignee: Vanderbilt University
    Inventor: Kenneth L. Brigham